P-328 - Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - An analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie
- Resource Type
- Abstract
- Source
- In
Annals of Oncology June 2017 28 Supplement 3:iii116-iii116 - Subject
- Language
- ISSN
- 0923-7534